raloxifene hydrochloride has been researched along with bradykinin in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 2 (50.00) | 2.80 |
Authors | Studies |
---|---|
Leitzbach, D; Linz, W; Madajka, M; Malinski, T; Weckler, N; Wiemer, G | 1 |
Au, CL; Huang, Y; Laher, I; Leung, FP; Leung, HS; Vanhoutte, PM; Yao, X; Yung, LM | 1 |
Gomez-Gutierrez, P; Perez, JJ | 1 |
Bachelard, H; Marceau, F | 1 |
4 other study(ies) available for raloxifene hydrochloride and bradykinin
Article | Year |
---|---|
Restoration of endothelial function via enhanced nitric oxide synthesis after long-term treatment of raloxifene in adult hypertensive rats.
Topics: Animals; Aorta, Thoracic; Blood Pressure; Body Weight; Bradykinin; Endothelium, Vascular; Female; Heart Rate; Hypertension; In Vitro Techniques; Male; Muscle Contraction; Muscle, Smooth, Vascular; Nitric Oxide; Ovariectomy; Raloxifene Hydrochloride; Rats; Rats, Inbred SHR; Selective Estrogen Receptor Modulators; Superoxides | 2005 |
Therapeutic concentrations of raloxifene augment nitric oxide-dependent coronary artery dilatation in vitro.
Topics: Animals; Bradykinin; Coronary Vessels; Estradiol; Estrogen Antagonists; Fulvestrant; In Vitro Techniques; Muscle, Smooth, Vascular; Nitric Oxide; Nitric Oxide Synthase Type III; Raloxifene Hydrochloride; Swine; Vasodilation; Vasodilator Agents | 2007 |
Discovery of a Bradykinin B2 Partial Agonist Profile of Raloxifene in a Drug Repurposing Campaign.
Topics: Animals; Antiviral Agents; Bradykinin; CHO Cells; COVID-19 Drug Treatment; Cricetulus; Drug Partial Agonism; Drug Repositioning; Inhibitory Concentration 50; Ligands; Raloxifene Hydrochloride; Receptor, Bradykinin B2 | 2020 |
Are noscapine and raloxifene ligands of the bradykinin B
Topics: Biological Assay; Bradykinin; Bradykinin Receptor Antagonists; Humans; Noscapine; Raloxifene Hydrochloride; Receptor, Bradykinin B1; Receptor, Bradykinin B2; Receptors, Bradykinin; Umbilical Veins | 2022 |